Avoro Capital Advisors reported a 6.1% stake in Monte Rosa Therapeutics GLUE · 3,725,000 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 6.1%
Last report: 7.1% · filed 25/02/14
Shares held: 3,725,000 sh
Class: Common Stock, par value $0.0001 per share
Stock: Monte Rosa Therapeutics GLUE
Holder: Avoro Capital Advisors
Event date: 25/06/30
Filed: 25/08/14

6.1% stake · −1.0pp from the last report

Stake: 6.1%
Last report: 7.1%
Since last report: −1.0pp

Monte Rosa Therapeutics trades, last 26 weeks

What else happened in Monte Rosa Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Avoro Capital Advisors's other 5% stake reports

Avoro Capital Advisors
5% stakeHemab Therapeutics Holdings
5% stake
Hemab Therapeutics Holdings
COAG
7.06% stake
3,298,236 sh
7.06% stake
Filed 08/14
Avoro Capital Advisors
5% stakeArrowhead Pharmaceuticals
5% stake
Arrowhead Pharmaceuticals
ARWR
9.64% stake
13,823,383 sh
9.64% stake
Filed 08/14
Avoro Capital Advisors
5% stakeAvalo Therapeutics
5% stake
Avalo Therapeutics
AVTX
4.44% stake
2,333,333 sh
4.44% stake
Filed 08/14
Avoro Capital Advisors
5% stakeScribe Therapeutics
5% stake
Scribe Therapeutics
SCTX
16.37% stake
3,088,888 sh
16.37% stake
Filed 07/30
Avoro Capital Advisors
5% stakeDamora Therapeutics
5% stake
Damora Therapeutics
DMRA
6.27% stake
3,783,000 sh
6.27% stake
Filed 05/15